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Until recently the laboratory diagnosis of infections has 
depended on the use of cultural identification, often coupled 
with biochemical tests. Increasingly, this process has been 
changed and refined with the development of rapid and 
accurate molecular methods. Most attention has focused 
on the detection of identifying genetic material, RNA or 
DNA; nucleic acid amplification techniques provide a rapid 
and sensitive method for microbial detection. However a 
new approach using Matrix-Assisted Laser Desorption/
Ionisation Time-Of-Flight (MALDI-TOF) Mass Spectro-
metry (MS) has emerged as a powerful tool for microbial 
identification and research. Mass spectrometry involves the 
ionisation of chemical compounds into charged molecules 
and measurement of their mass to charge (m/z) ratio. The 
development of ‘soft ionisation’ methods such as MALDI 
has widened the application of MS to the detection of large 
biological molecules, including polypeptides, glycoproteins 
and complex carbohydrates. The process involves mixing 
the microbiological sample with an energy-absorbent ma-
trix; constituents are ionised by laser energy and separated, 
based on the time taken to travel along a flight tube that 
depends on their mass-to-charge ratio. These data are used 
to construct a mass spectrum or peptide mass fingerprint 
(PMF) that is compared against a database of reference 
spectra, identifying the organism to genus, species or strain 
level. Highly abundant microbial proteins, mostly ribosomal 
proteins in the mass range 2-20 kDa, are the main contribu-
tors to the PMF for an individual organism and results can 
be generated in seconds and with a minimum of material. 
MALDI-TOF MS is a sensitive and very rapid techni-
que for analysing a wide range of microbial products. In 
addition to the identification of organisms it can provide 
useful information, for instance, on antibiotic susceptibility, 
through the detection of resistance-associated proteins (e.g. 
beta-lactamases). The potential for rapid, high-throughput 
analysis of protein products from complex mixtures makes 
MALDI-TOF MS an important technology in studying 
pathogenetic mechanisms. It can also be used to image 
proteins directly from intact tissue sections, a process known 
as imaging mass spectrometry (IMS). This can provide 
information on the relative concentration and spatial dist-
ribution of proteins within different areas of tissue (healthy 
and diseased). It is a cost-effective method for microbial 
detection, compared with molecular and immunological 
methods, however high setup costs may be a barrier to initial 
implementation and sometimes there can be difficulty in 
distinguishing genetically very similar organisms. 
The literature contains many examples of the benefits of 
using MALDI-TOF MS, for both clinical diagnosis and as 
a research tool in dermatology. The accurate classification 
of strains of Propionibacterium acnes at the proteomic level 
has provided a foundation for further molecular investiga-
tion to characterise the role of this organism in the patho-
genesis of acne (1, 2). Numerous case reports highlight the 
utility of MALDI-TOF MS (often supported by DNA/RNA 
sequencing) in the identification of new and rare organisms 
in clinical specimens, which might not otherwise be detec-
ted using conventional methods. Baran et al. (3) recently 
described a case of chronic lower leg wound infection with 
Kerstersia gyiorum (diagnosed by MALDI-TOF MS) in a 
patient with Buerger’s disease. They draw attention to the 
likelihood of misdiagnosis of this organism using bioche-
mical methods in isolation. The use of this technique is not 
restricted to bacteria and is finding wide acceptance as a 
rapid method for identifying fungi such as dermatophytes 
and yeasts isolated from clinical material (4, 5). 
In this issue Del Giudice and colleagues (6) report the 
first case of cellulitis caused by an emerging pathogen, 
Streptococcus halichoeri. They highlight the usefulness of 
MALDI-TOF for microbial identification in comparison to 
conventional methods. Results obtained from microbiolo-
gical samples using biochemical methods were discordant. 
Subsequent evaluation with MALDI-TOF mass spectro-
metry identified the organism as S. halichoeri. The use of 
MALDI-TOF MS in this case (supported by 16S rRNA gene 
sequencing) confirmed the cause of cellulitis.
The increasing use of modern molecular tools such as 
MALDI-TOF MS will result in the detection of more unu-
sual and unfamiliar microorganisms; but communication 
between clinicians and laboratory scientists will remain 
important in order to determine their pathogenic relevance 
as well as resistance patterns. Maintaining, and adding to, 
reference data bases where comparative information on the 
mass fingerprints is stored is key to the future success and 
application of this method.
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